Natasha Hunter

Also affiliated with Fred Hutch Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical Utility”.

The Long and Winding Road for Breast Cancer Biomarkers to Reach Clinical Utility

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2451

N/A

0DataRank · unranked

7 citations

Mark Kilgore, Nancy E. Davidson, Natasha Hunter

NOTCH1 PEST domain variants are responsive to standard of care treatments despite distinct transformative properties in a breast cancer model

Oncotarget(2022)10.18632/oncotarget.28200

N/A

0DataRank · unranked

7 citations

Morgan V. Pantone, Dong Ho Shin, Riley E. Bergman, Rory L. Cochran, David Chu +15 more

Matched FES and FDG PET imaging in patients with hormone receptor-positive, HER2+ advanced breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.1042

N/A

0DataRank · unranked

1 citations

Lanell M. Peterson, David A. Mankoff, Mark Muzi, Delphine L. Chen, Shaveta Vinayak +4 more

Fluoroestradiol (FES) and Fluorodeoxyglucose (FDG) PET imaging in patients with ER+, HER2-positive or HER2-negative metastatic breast cancer

Breast Cancer Research(2025)10.1186/s13058-025-01975-1

N/A

0DataRank · unranked

1 citations

Lanell M. Peterson, Jennifer M. Specht, David A. Mankoff, Mark Muzi, Delphine L. Chen +5 more